Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| US FDA advisory panel backs continued use of Amgen's Aranesp and Epogen pre ... - The Pharma Letter |
 |
 |
|
The Pharma Letter... remain on the market for anemia patients who do not yet require dialysis, despite an increased risk of stroke as identified in the TREAT clinical study. ...Amgen's Anemia Drug Aranesp Is Safe Before Kidney Dialysis, FDA Panel Says BloombergKidney Patients Not On Dialysis, FDA Advisers Recommend Continuation Of ... read more |
